Infectious disease expert and CEO of Wellness and Equity Alliance, Dr. Tyler B Evans, previously told Newsweek that there was "no clear evidence that this subvariant presents dramatically different symptoms from other recent strains. "We're still seeing common indicators like sore throat, nasal congestion, fatigue, and cough," he said.